Benefit-risk assessment: to quantify or not to quantify, that is the question

Authors


Z. Yuan, Epidemiology, Johnson and Johnson Pharmaceutical Research and Development, Titusville, NJ, USA. E-mail: zyuan6@its.jnj.com

Ancillary